GLP-1 payment model for employers
US$ 20.36
glp-1 tirzepatide vs semaglutide Retatrutide vs Comparative safety and side effects
Description
( 10.1016/j.neuroscience.2011.02.023) [DOI] [PMC free article] [PubMed] [Google Scholar] Loganathan J, Cohen AC, Kaloupis GM, Harris C, Chronopoulos A, James V, Hamilton J, Green S, Wallis A, Morgan S, et al
Hepatic effects of GLP-1 receptor agonists are increasingly recognised as clinically significant
CD gave substantial contribution to drafting the article or revising it critically for important intellectual content and final approval of the version to be published
doi:10.3109/00365521.2013.832366 85
